Skip to content
PubMed This is a summary of 63 peer-reviewed journal articles Updated
Neurology

Understanding Becker Muscular Dystrophy

At a Glance

Becker Muscular Dystrophy (BMD) is a genetic condition causing gradual muscle weakness due to partially functioning dystrophin protein. It progresses more slowly than Duchenne, with many individuals maintaining mobility and living active lives into mid-to-late adulthood.

Receiving a diagnosis of Becker Muscular Dystrophy (BMD) often brings a complex mix of emotions. For some, it may come after years of searching for answers to “clumsiness” or muscle cramps; for others, it may follow an initial, frightening misdiagnosis of Duchenne Muscular Dystrophy (DMD) [1]. It is natural to feel overwhelmed, but it is important to know that BMD is a distinct condition with its own unique timeline and a wide range of possibilities for a full, active life.

What is Becker Muscular Dystrophy?

Becker Muscular Dystrophy is a genetic condition that primarily affects the voluntary muscles—the ones used for walking, lifting, and moving [2]. It is caused by changes in the dystrophin gene, which is responsible for making a protein called dystrophin that acts like a shock absorber for muscle cells [3].

  • How it happens: In BMD, the body still produces the dystrophin protein, but it is either shorter than normal or produced in smaller amounts [3]. This allows the muscles to remain functional for much longer than they would in more severe forms of muscular dystrophy [4].
  • How common it is: BMD is rarer than Duchenne Muscular Dystrophy. Research estimates that BMD affects approximately 1.6 out of every 100,000 people globally [5].

Differentiating Becker from Duchenne

While BMD and DMD involve the same gene, the way they affect the body is very different. This is often explained by the reading frame rule, a biological principle that helps doctors predict how severe a mutation might be [6].

Feature Becker Muscular Dystrophy (BMD) Duchenne Muscular Dystrophy (DMD)
Dystrophin Protein Partially functional [3] Almost entirely absent [4]
Symptom Onset Highly variable; usually ages 5 to 60 [Muscular Dystrophy Association] Usually early childhood (ages 2 to 5) [1]
Walking Ability Often remain ambulatory (able to walk) into adulthood [7] Typically lost in early to mid-teens without treatment [2]
Life Expectancy Often well into mid-to-late adulthood [7] Historically shorter, though improving with care [2]

Living with Variability

One of the most defining characteristics of BMD is its clinical heterogeneity, which means the disease looks very different from one person to the next [7][8]. There is no “one-size-fits-all” timeline.

  • Movement and Mobility: Many people with BMD continue walking into their 30s, 40s, or even 60s [9]. Decline in muscle function tends to happen much more slowly and typically becomes more noticeable in adulthood rather than childhood [7].
  • Cardiac Health: The heart is also a muscle. While skeletal muscles may stay strong, the heart can be affected by the lack of dystrophin. This can lead to cardiomyopathy (weakness of the heart muscle), which is why regular heart check-ups are a critical standard of care, especially after age 16 [10][11].
  • The “Whole Person”: BMD can sometimes be associated with neurocognitive challenges, such as ADHD, anxiety, or specific learning difficulties [12][13]. Acknowledging these as part of the condition can help in getting the right support in school or at work.

Navigating the Emotional Journey

A diagnosis of BMD can be emotionally taxing, particularly if you were originally told it was DMD. The “relief” of a milder diagnosis often mixes with “grief” for the challenges that still remain.

  • Managing Uncertainty: Because BMD is so variable, it can be hard to plan for the future. Focusing on current function while maintaining a proactive care team can provide a sense of agency.
  • Support for the Mind: It is common to experience anxiety or depression when navigating a chronic illness. Mental health screening is now considered a vital part of comprehensive care for families living with dystrophinopathies [12].

Exploring This Guide

To help you navigate your journey with BMD, we have created the following resources:

Common questions in this guide

What is the difference between Becker and Duchenne Muscular Dystrophy?
While both conditions involve mutations in the dystrophin gene, people with Becker Muscular Dystrophy still produce a partially functional dystrophin protein. In Duchenne, the protein is almost entirely absent, which leads to an earlier onset and much more rapid progression of muscle weakness.
Will someone with Becker Muscular Dystrophy lose the ability to walk?
Mobility loss varies significantly among individuals. Because muscle decline happens much more slowly in BMD than in more severe forms of muscular dystrophy, many people continue walking into their 30s, 40s, or even 60s.
How does Becker Muscular Dystrophy affect the heart?
Because the heart is a muscle, the reduced amount of dystrophin protein can lead to cardiomyopathy, which is a weakness of the heart muscle. Regular cardiac screenings are a critical part of standard care to monitor and protect heart health, especially after age 16.
Can Becker Muscular Dystrophy affect mental health or learning?
Yes, it can be associated with neurocognitive challenges such as ADHD, anxiety, or specific learning difficulties. Comprehensive care for BMD now includes mental health screenings and educational support to help manage these aspects.
What causes Becker Muscular Dystrophy?
It is caused by genetic changes in the dystrophin gene. This change causes the body to produce a shorter or smaller amount of the dystrophin protein, which normally acts like a shock absorber to protect muscle cells from damage during movement.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific mutation was found in the genetic testing, and what does it suggest about the production of dystrophin?
  2. 2.At what age do you typically see heart or breathing changes in patients with this specific mutation?
  3. 3.Can you refer us to a physical therapist who specializes in Becker Muscular Dystrophy specifically, rather than general muscular dystrophy?
  4. 4.Is there a local or online support group for adults or parents specifically living with BMD?
  5. 5.How often should cardiac and respiratory screenings be performed based on the current age and symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Multi-Parametric Quantitative MRI in the Early Differential Diagnosis of Ambulatory Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.

    Peng F, Xu H, Xu T, et al.

    Journal of magnetic resonance imaging : JMRI 2025; (62(2)):457-467 doi:10.1002/jmri.29755.

    PMID: 40038055
  2. 2

    Orthotopic Heart Transplantation in Manifesting Carrier of Duchenne Muscular Dystrophy.

    Cullom C, Vo V, McCabe MD

    Journal of cardiothoracic and vascular anesthesia 2022; (36(8 Pt A)):2593-2599 doi:10.1053/j.jvca.2021.09.047.

    PMID: 34670720
  3. 3

    Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis.

    Weerkamp PMM, Mol EM, Sweere DJJ, et al.

    Brain sciences 2022; (12(11)) doi:10.3390/brainsci12111544.

    PMID: 36421868
  4. 4

    MLPA Analyses Reveal a Spectrum of Dystrophin Gene Deletions/Duplications in Pakistani Patients Suspected of Having Duchenne/Becker Muscular Dystrophy: A Retrospective Study.

    Ansar Z, Nasir A, Moatter T, et al.

    Genetic testing and molecular biomarkers 2019; (23(7)):468-472 doi:10.1089/gtmb.2018.0262.

    PMID: 31157985
  5. 5

    Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis.

    Salari N, Fatahi B, Valipour E, et al.

    Journal of orthopaedic surgery and research 2022; (17(1)):96 doi:10.1186/s13018-022-02996-8.

    PMID: 35168641
  6. 6

    [A predictive analysis of the association between clinical phenotypes and genotypes in children with Becker muscular dystrophy/Duchenne muscular dystrophy].

    Niu HH, Tao DY, Cheng SQ

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2020; (22(6)):602-607.

    PMID: 32571459
  7. 7

    Findings from the Longitudinal CINRG Becker Natural History Study.

    Clemens PR, Gordish-Dressman H, Niizawa G, et al.

    Journal of neuromuscular diseases 2024; (11(1)):201-212 doi:10.3233/JND-230178.

    PMID: 37980682
  8. 8

    Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study.

    Ricci G, Govoni A, Torri F, et al.

    Journal of neuromuscular diseases 2024; (11(2)):375-387 doi:10.3233/JND-221513.

    PMID: 38189759
  9. 9

    Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene.

    Davies KE, Vogt J

    Neuromuscular disorders : NMD 2024; (39()):5-9 doi:10.1016/j.nmd.2024.04.004.

    PMID: 38653179
  10. 10

    Electrocardiographic Changes in Jordanian Patients With Becker Muscular Dystrophy.

    Al-Raqad MK, Alwahsh S, Hejazi IS, et al.

    Cureus 2023; (15(10)):e47553 doi:10.7759/cureus.47553.

    PMID: 38022137
  11. 11

    Dilated cardiomyopathy as the initial presentation of Becker muscular dystrophy: a systematic review of published cases.

    Del Rio-Pertuz G, Morataya C, Parmar K, et al.

    Orphanet journal of rare diseases 2022; (17(1)):194 doi:10.1186/s13023-022-02346-1.

    PMID: 35549971
  12. 12

    Cognitive profile and neuropsychiatric disorders in Becker muscular dystrophy: A systematic review of literature.

    Ferrero A, Rossi M

    Neuroscience and biobehavioral reviews 2022; (137()):104648 doi:10.1016/j.neubiorev.2022.104648.

    PMID: 35367224
  13. 13

    Methylphenidate treatment of a Chinese boy with Becker muscular dystrophy combined with attention deficit hyperactivity disorder: a case report.

    Shen F, Zhou H

    Frontiers in neuroscience 2024; (18()):1459582 doi:10.3389/fnins.2024.1459582.

    PMID: 39659883

This page provides general informational about Becker Muscular Dystrophy for educational purposes only. Always consult a neurologist, cardiologist, or genetic specialist for a personalized diagnosis and care plan.

Get notified when new evidence is published on Becker muscular dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.